PIP4K2B and neoplasm: In our current study, the introduction of PIP4K2B reversed the tumor-promoting effects of miR-3064 in PC cells, suggesting that the gain of miR-3064 expression could result in the attenuation of tumor suppressor PIP4K2B, resulting in enhanced PC progression.